ASAPprime® Success Story


FreeThink successfully works with companies to increase the initially granted shelf-life at the time of registration for new products.



One international pharmaceutical company recently reported that it was granted a three-year shelf-life at launch for a new drug product in the EU, using ASAPprime® analysis and just three months of traditional ICH data (with commitment for ongoing monitoring).